Dr. Vadim Jucaud’s lab at the Terasaki Institute has developed a vascularized liver tissueoid-on-a-chip (LToC) platform that recapitulates key structural, functional, and immunological features of human liver tissue, enabling the study of liver regeneration and immune-mediated allograft rejection in a physiologically relevant human system.

Data was used from Veterans Affairs health system

Patients who were retreated with docetaxel had longer overall survival compared with those who switched to cabazitaxel

Findings were published in JAMA Network Open

A novel method to manipulate the inner structure of cells connects several scientific fields and could represent a significant step in the treatment of neurodegenerative diseases, such as Alzheimer’s and Parkinson’s disease.

University of Missouri researchers have released the world’s largest collection of protein models with quality assessment — a groundbreaking new resource that could accelerate drug development for diseases such as Alzheimer’s and cancer. The database, called PSBench, includes 1.4 million annotated protein structure models, all verified by independent experts. It gives scientists the reliable information they need to build more accurate artificial intelligence (AI) systems for assessing the quality of protein structure models, which is critical for developing future medical treatments.